Program for all days

Better Kidney Health
The Interconnected Kidney
Preserving Kidney Health
The Smart Kidney
Plenary Sessions
WCN Courses
Spotlight Sessions
Special Sessions
Global Kidney Policy Forum
Welcome Event
Topical Networking
Poster Sessions

28 March 2026

Time Session
2 p.m.
3:30 p.m.
Plenary Lecture 1: Donald Seldin Lecture - Dynamics of the Function and Regulation of the Endoplasmic Reticulum and WCN'26 Opening Ceremony (Kazutoshi Mori, Japan)
Jean Hamburger Award
MarcelloTonelli Moderator Canada
MasaomiNangaku Moderator Japan
SunitaBavanandan Moderator Malaysia
KornchanokVareesangthip YN Host Thailand
KazutoshiMori Speaker Japan
TakashiKadowaki Speaker Japan
  • Welcome and ISN Presidential Address
    MarcelloTonelli Speaker Canada
  • Jean Hamburger Award Presentation
  • Welcome Speech by JSN President
    MasaomiNangaku Speaker Japan
  • Welcome Speech by APSN President
    XueqingYU Speaker China
  • Welcome Speech by SPWG Chair
    Sydney Tang Speaker Hong Kong, China
  • Welcome Speech by the President of Japanese Medical Science Federation and Japanese Association of Medical Science
    TakashiKadowaki Speaker Japan
  • Dynamics of the Function and Regulation of the Endoplasmic Reticulum
    KazutoshiMori Speaker Japan
  • ISN Film Event Winner Presentation
Main Hall
3:45 p.m.
4:45 p.m.
HIT! High Impact Clinical Trials 1
DavidWheeler Moderator United Kingdom
KatherineTuttle Moderator United States
  • REMODEL Trial Overview: Framework and Key Outcomes
    PetterBjornstad Speaker United States
  • Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial
    DavidCherney Speaker Canada
  • Aldosterone Blockade for Health Improvement Evaluation in End-stage Renal Disease Trial
    (ACHIEVE)
    MichaelWalsh Speaker Canada
  • B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil
    JulienHogan Speaker France
  • Q&A Session
Main Hall

29 March 2026

Time Session
9:25 a.m.
10:55 a.m.
HIT! High Impact Clinical Trials 2 - New Insights Into Ongoing Trials
AdeeraLevin Moderator alevin@providencehealth.bc.caCanada
Andrea Viecelli Moderator Switzerland
RobertoPecoits-Filho Moderator United States
  • RESOLVE Trial: Sodium Concentration in Dialysis Populations — a Global Cluster Randomized Study
    MegJardine Speaker Australia
  • Q&A
  • Key Aspects of the VOICE Clinical Trial on Anemia in Dialysis Patients
    ShuchiAnand Speaker sanand3@health.ucdavis.eduUnited States
  • Q&A
  • The Renal Life Cycle: Development, Maturity, and Decline
    HiddoLambers Heerspink Speaker Netherlands
  • Q&A
  • Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far
    Joint Presentation
    Selvin Sundar RajMani Speaker India
    SuceenaAlexander Speaker India
  • Q&A
  • ASPIRE Trial: Aspirin Use in Dialysis Patients in China
    XueqingYU Speaker China
  • Q&A
Main Hall
11:35 a.m.
12:35 p.m.
Plenary Lecture 2: Podocytopathies: Knowns and Unknowns (Paola Romagnani, Italy)
Bywaters Award
AkiraNishiyama Moderator Japan
LizLightstone Moderator United Kingdom
Sydney Tang Moderator Hong Kong, China
Ming-YanJiang YN Host Taiwan
PaolaRomagnani Speaker Italy
  • Bywaters Award Presentation
  • Podocytopathies: Knowns and Unknowns
    PaolaRomagnani Speaker Italy
Main Hall
2:10 p.m.
3:10 p.m.
HIT! High Impact Clinical Trials 3
In IgA Nephropathy
HeatherReich Moderator Canada
Sydney Tang Moderator Hong Kong, China
YusukeSuzuki Moderator Japan
  • Opening & Introduction
    Sydney Tang Speaker Hong Kong, China
  • Efficacy and Safety Results of Atrasentan in Patients With IgA Nephropathy on Sodium‚ äìglucose Co-transporter 2 Inhibitors: Phase II, Randomized, Placebo-controlled, Crossover Trial (Assist)
    HiddoLambers Heerspink Speaker Netherlands
  • Q&A
  • Efficacy and Safety of a Targeted-release Formulation of Budesonide (HR19042 Capsules) in Patients With Primary IgA Nephropathy: A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2/3 Trial
    XiaobingYang Speaker China
  • Q&A
  • Efficacy and Safety of Iptacopan in Patients With IgA Nephropathy (IgAN): Final 24-month Results From the Phase III APPLAUSE-IgAN Study
    VladoPerkovic Speaker Australia
  • Q&A
  • Closing Remarks
Main Hall
3:50 p.m.
4:50 p.m.
Hot Debate: Friend or Foe: SUMOylation in Kidney Injury and Repair
ShigeruShibata Moderator Japan
  • SUMOylation of Podocin Reverses the Progression of Diabetic Kidney Disease
    PedroGeraldes Speaker Pedro.Geraldes@USherbrooke.caCanada
  • SUMOylation Activates β-Catenin and Contributes to Kidney Fibrosis
    ZhengDong Speaker United States
Main Hall

30 March 2026

Time Session
9:25 a.m.
10:55 a.m.
HIT! High Impact Clinical Trials 4
KeiFukami Moderator Japan
LizLightstone Moderator United Kingdom
  • Effect of a 12-week Intradialytic Cycling Intervention on Hemodialysis-induced Myocardial Stunning: A Multi-centre Randomized Controlled Trial
    ClaraBohm Speaker Canada
  • TEACH-PD Cluster Randomized Controlled Trial: Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes
    JosephineChow Speaker Australia
  • Effect of Finerenone on Circulating Biomarkers: A CONFIDENCE Analysis
    MarioBerger Speaker mario.berger@bayer.comGermany
  • Effect of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-creatinine Ratio by Age and Sex in the CONFIDENCE Trial
    RajivAgarwal Speaker United States
  • Estimated Glomerular Filtration Rate, Systolic Blood Pressure, and Urinary Albumin-to-creatinine Ratio — Unravelling the Interplay in Combination: Findings From the CONFIDENCE Trial
    RajivAgarwal Speaker United States
  • Lowering-Hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective, Multicenter, Double Blind Randomized Controlled Trial
    Naya Huang Speaker huangnaya@163.comChina
Main Hall
11:35 a.m.
12:35 p.m.
Plenary Lecture 3: The Potential of Polypills in CKD (Anthony Rodgers, Australia)
Schrier Award Presentation
LilyMushahar Moderator Malaysia
MotokoYanagita Moderator Japan
RobertKalyesubula Moderator Uganda
Marques Shek NamNg YN Host Hong Kong, China
AnthonyRodgers Speaker Australia
  • Schrier Award Presentation
  • The Potential of Polypills in CKD
    AnthonyRodgers Speaker Australia
Main Hall
2:10 p.m.
3:10 p.m.
Advances in CKD: in collaboration with the Lancet
AdeeraLevin Moderator alevin@providencehealth.bc.caCanada
JenniferLees Moderator United Kingdom
MidoriSakashita Moderator Japan
  • Advances in the Diagnosis and Detection of CKD
    LuxiaZhang Speaker China
  • Advances in Understanding the Impact of Sex on Kidney Health and Disease
    KateStevens Speaker United Kingdom
  • Advances in CKD Therapeutics in the Context of Complex Disease Interactions
    AndrejSkoberne Speaker Slovenia
  • Q&A
Main Hall
3:50 p.m.
4:50 p.m.
Anemia Care in CKD: Recent Evidence and Future Directions
Chuan-MingHao Moderator China
  • KDIGO Updates on Management of CKD Anemia
    WolfgangWinkelmayer Speaker United States
  • Why CKD Anemia Care Differs Across Regions
    SunitaBavanandan Speaker Malaysia
  • Beyond Erythropoiesis-stimulating Agents and Iron: Navigating the Future of Anemia of Chronic Kidney Disease Management
    Kai-UweEckardt Speaker Germany
  • Q&A
Main Hall

31 March 2026

Time Session
9:10 a.m.
10:40 a.m.
Genetic Testing in Kidney Disease: Interpretation and Patient Perspectives
RoserTorra Moderator Spain
  • Genetic Pretesting — Is More Always Better?
    RoserTorra Speaker Spain
  • The Test: Nephro-genomic Board Simulation: Variant Scientist X Genetic Nephrologist
    DanielGale Speaker United Kingdom
  • Risk Alleles and Low-penetrance Variants in Nephrology: Gaps in Evidence
    JanewitWongboonsin Speaker Thailand
  • The Patient Voice
    SusieGear Speaker United Kingdom
  • Q&A
Main Hall
11 a.m.
12 p.m.
ISN-JSN-APSN Joint Session: Delivering Kidney Care in Humanitarian Crises
KeiFukami Moderator Japan
LilyMushahar Moderator Malaysia
SerhanTuglular Moderator Turkey
  • The ISN Role in Humanitarian Kidney Care
    AliAbu-Alfa Speaker abualfa@aub.edu.lbLebanon
  • Disaster Preparedness in Kidney Care: Pitfalls and Solutions
    SerhanTuglular Speaker Turkey
  • Earthquake Disaster: Lessons Learnt from Japan
    KeiFukami Speaker Japan
  • Resilient Kidney Care: Adaptation and Recovery After a Disaster
    SabineKaram Speaker United States
  • Q&A
Main Hall
12:10 p.m.
1:10 p.m.
Plenary Lecture 4: Hugh de Wardener Lecture - Creating Paradigm Shifts in Medical Diagnostics Using Liquid Biopsy (Dennis Lo, Hong Kong, China)
MegJardine Moderator Australia
ShuchiAnand Moderator sanand3@health.ucdavis.eduUnited States
Yogeshni Chandra YN Host Fiji
Yuk Ming DennisLO Speaker Hong Kong, China
  • Creating Paradigm Shifts in Medical Diagnostics Using Liquid Biopsy
    Yuk Ming DennisLO Speaker Hong Kong, China
  • Congress Closing
Main Hall